Pharma Blog Watch
Effects
of Zocor's Pricing Change (Drug Channels)
Who are the winners and losers
in the continuing Zocor-pricing issue? In his entry, blogger Adam Fein reports
on who will be positively or negatively affected by Merck's lowering of the cholesterol
drug's price.
Retroactive
Criticism Doesn't Help (DrugWonks.com)
"The latest broadside against
the FDA is by Congressman Waxman, who argues the FDA is doing a lousy job by not
prosecuting and attacking companies who are producing inferior products, engaging
in mislabeling or selling suspicious goods
I call it regulation by body
count, since it requires people to die or be harmed in order for a regulatory
or enforcement act to take place," writes blogger Robert Goldberg. In his
entry, Goldberg decries recent FDA criticism as too heavy-handed and after-the-fact.
Upcoming Events
-
21Oct